DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions

Arch Intern Med. 2010 Jan 11;170(1):109-10. doi: 10.1001/archinternmed.2009.459.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Anti-HIV Agents / administration & dosage*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Dose-Response Relationship, Drug
  • Drug Resistance, Viral
  • Emtricitabine
  • Female
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • Humans
  • Lopinavir
  • Male
  • Middle Aged
  • Organophosphonates / administration & dosage
  • Patient Compliance
  • Pyrimidinones
  • RNA, Viral / analysis
  • Randomized Controlled Trials as Topic
  • Stavudine / administration & dosage
  • Tenofovir
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Pyrimidinones
  • RNA, Viral
  • Deoxycytidine
  • Lopinavir
  • Tenofovir
  • Stavudine
  • Emtricitabine
  • Adenine